After surgical removal of the prostate to treat prostate cancer, clinicians monitor Prostate Specific Antigen (PSA) levels. Persistently elevated PSA levels indicate residual cancer and are linked to ...
Editor's note: second of two parts; read part one here. In the first part of our series, we described how PSA is used as a screening tool to help detect prostate cancer in men who don't have symptoms.
The European Society for Medical Oncology has updated its clinical practice guidelines for the management of localised prostate cancer and biochemical recurrence, refining diagnostic pathways and ...
The journey through prostate cancer treatment marks a significant chapter in many men’s lives, with surgery often serving as a pivotal turning point toward recovery. While the removal of cancerous ...
Clinical Trials—Real-World Data to Build a Future for Our Patients In the article that accompanies this editorial, Kwak et al 6 demonstrate using individual patient data from randomized trials that ...
WEST LAFAYETTE, Ind. — A new tool could help save lives by predicting prostate cancer relapse 14 months earlier than current standard methods. The tool, a computer model, makes its predictions by ...
A recent BBC investigation questioned the accuracy of prostate-specific antigen (PSA) self-tests – rapid at-home tests for men worried about prostate cancer. The BBC analysed five of these tests using ...
When men with advanced prostate cancer develop radiographic progression while taking enzalutamide, they frequently show little to no rise in prostate-specific antigen (PSA), according to a post hoc ...